title: [Protective effects of tetramethylpyrazine on rat myocardial cells infected by Coxsackie virus B3 and its signal transduction mechanism].
abstract: OBJECTIVE
  To study the protective effects of tetramethylpyrazine (TMPZ) on rat myocardial cells infected by Coxsackie virus B3 (CVB3) and its signal transduction mechanism.
  
  
  METHODS
  The cultured myocardial cells of neonatal Sprague-Dawley rats were randomly treated with CVB3, CVB3+TMPZ (100 micromol/L), TMPZ (100 micromol/L) (negative control) or DMEM (blank control). After treatment, the beating rate of myocardial cells and the LDH activity in the culture fluid were measured. Cell viability was ascertained with MTT assay. Western blot was used to study the expression of nuclear factor kappa-B (NF-kappaB) protein in myocardial cells.
  
  
  RESULTS
  The beating rate of myocardial cells in the untreated CVB3 infection group was significantly lower than that in the TMPZ-treated CVB3 infection group (32.0+/-3.6 bpm vs 84.3+/-3.5 bpm, P<0.01). The LDH activity and NF-kappaB expression in the TMPZ-treated CVB3 infection group was significantly reduced when compared with untreated CVB3 infection group (P<0.05, P<0.01, respectively). Cell viability 7 days after CVB3 infection in the TMPZ-treated group was higher than that in the untreated CVB3 infection group (86.7+/-2.7% vs 35.3+/-3.4%; P<0.01).
  
  
  CONCLUSIONS
  TMPZ can provide protective effects on rat myocardial cells infected by CVB3, possibly by an inhibition of the activity of NF-kappaB in myocardial cells.
authors.affiliation: Department of Emergency, Xiangya Hospital, Central South University, Changsha, China. qianzhx@hotmail.com
authors.forename: Zhao-Xin
authors.initials: ZX
authors.lastname: Qian
authors.forename: Han
authors.initials: H
authors.lastname: Huang
authors.forename: Xiao-Juan
authors.initials: XJ
authors.lastname: Lin
mesh_terms: D000818:Animals; D019610:Cytoprotection; D029822:Enterovirus B, Human; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009205:Myocarditis / Q000188:drug therapy; D032383:Myocytes, Cardiac / Q000187:drug effects* / Q000821:virology; D016328:NF-kappa B / Q000032:analysis / Q000502:physiology; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
chemical_list: D016328:NF-kappa B; D011719:Pyrazines; D007770:L-Lactate Dehydrogenase; C017953:tetramethylpyrazine